Abstract:Bis(7)-tacrine was evaluated for efficacy on memory retention in mice 17 days of age and 30 days of age. The tests used were a passive-avoidance response test and a measure of spontaneous motor activity. Also, possible drug-induced hepatotoxicity and acute drug toxicity were evaluated. Behavioral studies were performed using a step-through task and an open-field test with a 24-h interval between training and evaluation tests. Bis(7)-tacrine (0.06-20 micromol/kg) was subcutaneously injected 30 min prior to the first session of both test types. During the training session of the step-through task, bis(7)-tacrine treatment reduced (by 46%, P<0.01) the number of avoidable electric shocks (footshocks) only at a high dose of 20 micromol/kg in mice 17 days of age, but dose-dependently decreased the number of footshocks (10-56%, P<0.001) in mice 30 days of age. Bis(7)-tacrine treatment at all doses tested did not produce any detectable changes in retention latency in mice 17 days of age, but the drug significantly prolonged retention latency at low doses (1.25 and 2.50 micromol/kg), and not high doses (5-20 micromol/kg), in mice 30 days of age. In the open-field test, bis(7)-tacrine decreased spontaneous motor activity in the acquisition session only at a high dose of 20 micromol/kg in mice 17 days of age and 30 days of age (by 28 and 45%, respectively), but did not affect spontaneous motor activity in the recall session. Bis(7)-tacrine treatment at a dose of 20 micromol/kg produced a more potent hepatotoxic effect in mice 30 days of age than in mice 17 days of age, (P<0.05), and the drug caused acute toxicity with comparable potencies in mice of both age groups. In conclusion, mice 30 days of age seemed to be more sensitive than mice 17 days of age to bis(7)-tacrine-induced cognitive function enhancement and hepatotoxicity. Bis(7)-tacrine appears to be more potent and more selective as a cognitive function-enhancing agent than tacrine.

Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studies

Mechanism of bis(7)-tacrine inhibition of GABA-activated current in cultured rat hippocampal neurons

Novel dimeric bis(7)-tacrine proton-dependently inhibits NMDA-activated currents.

Novel Dimeric Acetylcholinesterase Inhibitor Bis(7)-Tacrine, But Not Donepezil, Prevents Glutamate-Induced Neuronal Apoptosis By Blocking N-Methyl-D-Aspartate Receptors

Bis(7)-Tacrine, a promising anti-Alzheimer's agent, attenuates glutamate-induced cell injury in primary cultured cerebrocortical neurons of rats

Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors

Bis(7)‐tacrine Attenuates Β Amyloid‐induced Neuronal Apoptosis by Regulating L‐type Calcium Channels

Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase.

Neuroprotection Via Inhibition of Nitric Oxide Synthase by Bis(7)-Tacrine

Actions of bis(7)-tacrine and tacrine on transient potassium current in rat DRG neurons and potassium current mediated by KV4.2 expressed in Xenopus oocyte

Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABA(A) receptor antagonist

Bis(7)-tacrine, a Promising Anti-Alzheimer's Dimer, Affords Dose- and Time-Dependent Neuroprotection Against Transient Focal Cerebral Ischemia

Inhibition by bis(7)-tacrine of 5-HT-activated current in rat TG neurons.

Inhibition by Bis(7)-Tacrine of Native Delayed Rectifier and KV1.2 Encoded Potassium Channels

Effects of Bis(7)-Tacrine, A Novel Anti-Alzheimer'S Agent, on Rat Brain Ache

Promising anti-Alzheimer’s dimer bis(7)-tacrine reduces β-amyloid generation by directly inhibiting BACE-1 activity

Protection against ischemic injury in primary cultured astrocytes of mouse cerebral cortex by bis(7)-tacrine, a novel anti-Alzheimer's agent

Bis(7)-tacrine, a Novel Acetylcholinesterase Inhibitor, Reverses AF64A-induced Deficits in Navigational Memory in Rats.

Attenuation of Scopolamine-Induced Deficits in Navigational Memory Performance in Rats by Bis(7)-Tacrine, a Novel Dimeric AChE Inhibitor.

Mitochondrial proteomic analysis and characterization of the intracellular mechanisms of bis(7)-tacrine in protecting against glutamate-induced excitotoxicity in primary cultured neurons.

Evaluation of acute bis(7)-tacrine treatment on behavioral functions in 17-day-old and 30-day-old mice, with attention to drug toxicity.